The competitive cost of antibiotic resistance in Mycobacterium tuberculosis.
about
Origin, spread and demography of the Mycobacterium tuberculosis complexThe past and future of tuberculosis researchHigh functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demographyNew target for inhibition of bacterial RNA polymerase: 'switch region'Molecular Typing of Mycobacterium Tuberculosis Strains: A Fundamental Tool for Tuberculosis Control and EliminationNegligible risk of inducing resistance in Mycobacterium tuberculosis with single-dose rifampicin as post-exposure prophylaxis for leprosyThe Importance of First Impressions: Early Events in Mycobacterium tuberculosis Infection Influence OutcomeNew agents for the treatment of drug-resistant Mycobacterium tuberculosisTranslating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosisThe fitness costs of antibiotic resistance mutationsExtensively drug-resistant tuberculosis: epidemiology and managementData needs for evidence-based decisions: a tuberculosis modeler's 'wish list'Evolution of drug resistance in tuberculosis: recent progress and implications for diagnosis and therapyInsights from genomic comparisons of genetically monomorphic bacterial pathogensHigh Sequence Variability of the ppE18 Gene of Clinical Mycobacterium tuberculosis Complex Strains Potentially Impacts Effectivity of Vaccine Candidate M72/AS01EGain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulenceRapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosisWhat can we offer to 3 million MDRTB household contacts in 2016?Slow elimination of multidrug-resistant tuberculosisThe population dynamics and control of tuberculosisHigh rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from?Are survey-based estimates of the burden of drug resistant TB too low? Insight from a simulation studyFitness of Mycobacterium tuberculosis strains of the W-Beijing and Non-W-Beijing genotypeRapid experimental evolution of pesticide resistance in C. elegans entails no costs and affects the mating systemHeightened vulnerability to MDR-TB epidemics after controlling drug-susceptible TBInterplay in the selection of fluoroquinolone resistance and bacterial fitnessGenomic diversity among drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis with identical DNA fingerprintsPervasive sign epistasis between conjugative plasmids and drug-resistance chromosomal mutationsCompensatory evolution of pbp mutations restores the fitness cost imposed by β-lactam resistance in Streptococcus pneumoniaeDynamics of antibiotic resistant Mycobacterium tuberculosis during long-term infection and antibiotic treatmentPre-existing isoniazid resistance, but not the genotype of Mycobacterium tuberculosis drives rifampicin resistance codon preference in vitroMolecular mechanisms of drug resistance in natural Leishmania populations vary with genetic backgroundEstimating fitness by competition assays between drug susceptible and resistant Mycobacterium tuberculosis of predominant lineages in Mumbai, IndiaReduced virulence of an extensively drug-resistant outbreak strain of Mycobacterium tuberculosis in a murine modelWhole genome sequencing based characterization of extensively drug-resistant Mycobacterium tuberculosis isolates from PakistanWhole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P - Insights into a Mechanism of Resistance EscalationTransmission of Multidrug-Resistant and Drug-Susceptible Tuberculosis within Households: A Prospective Cohort StudyEpidemiology and Clinical Characteristics of Pediatric Drug-Resistant Tuberculosis in Chongqing, ChinaThe Role of Adherence and Retreatment in De Novo Emergence of MDR-TBVirulence of Mycobacterium tuberculosis after Acquisition of Isoniazid Resistance: Individual Nature of katG Mutants and the Possible Role of AhpC
P2860
Q21131591-8D9D036E-A782-4BDC-8D5D-5FEACCF25A00Q21559415-00FE090D-9F57-41FC-8247-C75AB4F0E64DQ21563563-C5BB6631-E98E-4EEE-9C1F-E17C9268A020Q24634933-5E6C83FA-A7E8-4AB4-A887-0C14AD292C6AQ26741145-6BF4D98B-26AB-454B-8B11-4B5D61660D7BQ26748597-627421D5-28AE-495D-9892-162C3863269DQ26751427-34D4EAA1-4358-45C5-91A9-1BC75B43C418Q26751463-D06F566A-EDAB-4FD3-9EC7-135993C58134Q26824812-317E8C98-D066-4D89-A18E-AF8252DC3C9BQ26825334-7DD9842B-37E7-48BD-B556-E06041DE97EEQ26830094-E8BCCDDB-F7F1-4A13-A1AE-2F599C75004EQ27015848-A1492DA4-F534-455F-B6A0-23046100F08DQ27016579-1638887B-BF47-4244-8AE4-FE19B6B0B84BQ27023806-E5B84E58-5B45-4A88-ACB7-F01C2D4EC230Q27316557-C86F272F-D6CC-4987-9437-7D2193D86283Q27318203-62E14B65-33FB-42F8-B768-B5C54D01FBDFQ27342229-B77F84B9-0C50-4AA6-B484-E2CA08EB46E3Q28066845-9752D8E2-DEDC-4878-B8EC-EA41AD61C33DQ28278696-70EDC823-7798-4675-BA3A-6AE0031F3183Q28282446-FC5E3D53-CDE1-47DC-AF6B-B0A4FACE6FACQ28365057-72EF5180-0602-49D8-9E84-FA6A7FAF6356Q28472943-49E2145F-CFAE-4257-93C7-467F9D30E582Q28473702-7A065611-9DD5-4429-A1AC-617F9750F648Q28474011-E67141E1-0D36-4947-BABA-B0882D012E09Q28475553-DF3C09D7-846F-4B10-AC49-F935F2ABEC85Q28475870-B402AC5F-9A5D-4ADF-BCA0-7CB4C365CE43Q28476294-52ECA6EA-5666-43B1-A54B-AEF219B93807Q28476356-A0440640-C3A5-475C-B48B-581CDAFD0B97Q28477183-64CA4B2A-7737-4286-8EB6-9BF6AF4628C7Q28478602-5ABA7AE6-A50B-4A35-BCEF-A10BE2383B7DQ28478663-5B863220-D27C-46FB-B1E3-29B97DD7D782Q28481297-07ECA5D0-1309-4ED9-B5CF-0DD560FB165CQ28481689-00332665-82D2-4301-8828-BAD498B8FBD2Q28537876-FEEB948B-3E3C-480C-ADA2-C21B867E3ACDQ28543682-00449159-760C-48B5-AA15-F27AAB09ACC4Q28547769-EA18E9B0-48B4-4F71-BF8D-7309D3BF8952Q28548584-2F925EFF-F577-4BD2-9AE7-7AAF8846795EQ28550637-5BD4D1CD-CE63-4A0F-B0BD-78E8A4BC884EQ28550707-96FF8DF3-DC01-41E1-BFF5-BA30C22D985FQ28554450-D63BF52D-CD94-4F84-A7A0-DB5E20D36BD7
P2860
The competitive cost of antibiotic resistance in Mycobacterium tuberculosis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The competitive cost of antibiotic resistance in Mycobacterium tuberculosis.
@en
type
label
The competitive cost of antibiotic resistance in Mycobacterium tuberculosis.
@en
prefLabel
The competitive cost of antibiotic resistance in Mycobacterium tuberculosis.
@en
P2093
P356
P1433
P1476
The competitive cost of antibiotic resistance in Mycobacterium tuberculosis.
@en
P2093
Clara Davis Long
Gary K Schoolnik
Peter M Small
Sebastien Gagneux
P304
P356
10.1126/SCIENCE.1124410
P407
P577
2006-06-01T00:00:00Z